Health Care
ASCENDIS PHARMA A/S ASND
$227.83
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1300 by number of owners
% of all portfolios
0.00%
Rank #1259 by combined value
Net managers Q2 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.1%
of Polen Capital's portfolio
Live price
Compare with the quarter-end price of $227.83 reported in the 13F
Superinvestors holding ASND
| Recent activity | |||
|---|---|---|---|
| Polen Capital · Polen Capital Management | 0.1% | ▲ New | $5.0M |